Luo M Y, Yan D, Wang X, Wang Y Y, Li H L, Li Y F, Gao F, Zhang C, Zeng Y L
People's Hospital of Henan University, Zhengzhou 450003, China People's Hospital of Henan Province, Zhengzhou 450003, China.
People's Hospital of Zhengzhou University, Zhengzhou 450003, China People's Hospital of Henan Province, Zhengzhou 450003, China.
Zhonghua Gan Zang Bing Za Zhi. 2025 Jul 20;33(7):667-673. doi: 10.3760/cma.j.cn501113-20231123-00222.
To explore the effect of psoas muscle index (PMI) and construct a machine learning model to validate the 180-day prognosis in patients with decompensated liver cirrhosis. Retrospective data were collected from patients with decompensated liver cirrhosis at Henan Provincial People's Hospital from January 2022 to November 2022. The area of the psoas muscle index (PMI) at the level of the third lumbar vertebra was measured and calculated based on the abdominal X-ray computed tomography images stored in the Eastern China Hospital Information System (HIS). Patients were divided into low PMI and normal PMI groups according to the receiver operating characteristic curve. Patients clinical data and complication status were collected.The general conditions of both groups were compared using a -test, chi-square test, and Mann-Whitney test. The Kaplan-Meier method was applied for survival analysis. The outcome variable was 180-day mortality, and variables were selected using Cox and LASSO regression. The dataset was divided into training and testing sets in a 7∶3 ratio. Machine learning algorithms were used to build models in the training set, and model performance was validated by the test set. The model for MELD-Na score was compared with the model for End-Stage Liver Disease score. A total of 298 patients with decompensated liver cirrhosis were included.The MELD scores, Child-Pugh classification, and NRS2002 scores, along with the incidence rate of complications such as ascites, hepatic encephalopathy, infections, and gastrointestinal bleeding, were significantly higher in the low PMI than the normal PMI group, with statistically significant differences (<0.05). The area under a receiver operating characteristic curve for the extreme gradient boosting model was higher than traditional clinical scores (MELD score 0.658, MELD_Na score 0.719) in the machine learning model. Furthermore, the application of SHAP results model indicated that PMI, hemoglobin, NRS2002 score, direct bilirubin, and blood ammonia were important factors in predicting the prognosis of patients with decompensated liver cirrhosis. A low PMI is closely related to poorer survival rates and the development of complication rates in patients with decompensated liver cirrhosis. The machine learning prediction model based on this construction, especially extreme gradient boosting, has favorable predictive performance, which is superior to the traditional clinical scoring system and can provide patients with the most accurate risk assessment and individualized treatment plan.
探讨腰大肌指数(PMI)的作用,并构建机器学习模型以验证失代偿期肝硬化患者的180天预后。收集2022年1月至2022年11月在河南省人民医院就诊的失代偿期肝硬化患者的回顾性数据。根据华东医院信息系统(HIS)中存储的腹部X线计算机断层扫描图像测量并计算第三腰椎水平的腰大肌指数(PMI)面积。根据受试者工作特征曲线将患者分为低PMI组和正常PMI组。收集患者的临床资料和并发症情况。两组的一般情况采用t检验、卡方检验和曼-惠特尼U检验进行比较。采用Kaplan-Meier法进行生存分析。结局变量为180天死亡率,变量采用Cox和LASSO回归进行选择。数据集按7∶3的比例分为训练集和测试集。使用机器学习算法在训练集中构建模型,并通过测试集验证模型性能。将MELD-Na评分模型与终末期肝病评分模型进行比较。共纳入298例失代偿期肝硬化患者。低PMI组的MELD评分、Child-Pugh分级、NRS2002评分以及腹水、肝性脑病、感染和胃肠道出血等并发症的发生率均显著高于正常PMI组,差异有统计学意义(P<0.05)。在机器学习模型中,极端梯度提升模型的受试者工作特征曲线下面积高于传统临床评分(MELD评分0.658,MELD_Na评分0.719)。此外,SHAP结果模型的应用表明,PMI、血红蛋白、NRS2002评分、直接胆红素和血氨是预测失代偿期肝硬化患者预后的重要因素。低PMI与失代偿期肝硬化患者较差的生存率和较高的并发症发生率密切相关。基于此构建的机器学习预测模型,尤其是极端梯度提升模型,具有良好的预测性能,优于传统临床评分系统,可为患者提供最准确的风险评估和个体化治疗方案。